Log In
BCIQ
Print this Print this
 

Sprix, ketorolac tromethamine (ROX-888)

  Manage Alerts
Collapse Summary General Information
Company Egalet Corp.
DescriptionIntranasal ketorolac analgesic
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionCyclooxygenase (COX) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsManagement of acute moderate to severe pain; Treat pain in patients who have undergone major abdominal surgery; Treat post-operative pain
Regulatory Designation
PartnerTeva Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$7.0M

$7.0M

0


 Deals Details
Get a free BioCentury trial today